LyP-1 Pep-LNP
Cat. No.: TDLD-0126-LD115
LyP-1 Pep-LNP
LyP-1 Pep-LNP is an advanced peptide-functionalized lipid nanoparticle (LNP) engineered for targeted delivery of therapeutic agents, leveraging the LyP-1 peptide which binds to tumor cells, enhancing specific cargo delivery to tumors. Applications include developing targeted cancer therapeutics and studying tumor-targeting mechanisms. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear All
For Research Use Only. Not for Diagnostic or Treatment Applications.
| Payload Type | mRNA |
| Payload | Empty; EGFP mRNA; Firefly Luciferase mRNA; mCherry mRNA; GFP mRNA; OVA mRNA; EPO mRNA; Renilla Luciferase mRNA; Gaussia Luciferase mRNA; Beta-galactosidase mRNA; Cre mRNA; mOrange mRNA; tdTomato mRNA; EYFP mRNA; Others |
| Capping | Cap 1 |
| Modification | Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other |
| Module Type | Peptide |
| Targeting Module | LyP-1 Peptide |
| Target | Tumor |
| Lipid Formulation | DLin-MC3-DMA; LP-01; ALC-0315; SM102; Other |
| Dye | Unlabeled; DiR; DiD; DiO; DiI; Other |
| Application | Control; Targeted Delivery; Gene Therapy |
| Format | Liquid |
| Concentration | 0.1 mg/mL; 0.2 mg/mL; Other (Please Specify) |
| Size | 65-120 nm |
| PDI | < 0.2 |
| Zeta | ± 20.0 mV |
| Encapsulate Efficiency | >90% |
| Shipping | Dry Ice |
| Storage | Store at -80°C |
Related Products
HAIYPRH Pep-LNP (TDLD-0126-LD161)
VTLTYEFAAGPRD Pep-LNP (TDLD-0126-LD151)
GPLGVRGC Pep-LNP (TDLD-0126-LD95)
NGR Pep-LNP (TDLD-0825-LD77)
Cy5-labeled EGFP mRNA-LNP (TDLD-0825-LD22)
GLP-1 Pep-LNP (TDLD-0126-LD92)
Dcpep Pep-LNP (TDLD-0126-LD160)
Targeted CD5 Ab-LNP (TDLD-0825-LD66)
Online Inquiry
